Cormorant Asset Management’s Celgene Corp CELG Stock Holding History

Cormorant Asset Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-100,000	Closed	-$10M	–	97
2016 Q1	$10M	Buy	+100,000	New	+$10.3M	1.51%	27
2015 Q1	–	Sell	-300,000	Closed	-$33.6M	–	75
2014 Q4	$33.6M	Buy	+300,000	New	+$31.6M	5.17%	3
2014 Q3	–	Sell	-200,000	Closed	-$17.2M	–	71
2014 Q2	$17.2M	Buy	+200,000	New	+$15.2M	4.55%	6
2014 Q1	–	Sell	-240,000	Closed	-$20.3M	–	56
2013 Q4	$20.3M	Buy	+240,000	New	+$19M	5.88%	6

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Cormorant Asset Management's CELG Position: Q2 2016 in Review

Cormorant Asset Management sold out of Celgene Corp (CELG) in Q2 2016, closing a stake of 100,000 shares — an estimated $10M sold.

Cormorant Asset Management first reported a position in CELG in Q4 2013 and held it in 4 quarters. The position peaked at $33.6M in Q4 2014. 1,218 funds tracked by Wall St. Rank hold CELG as of Q2 2016.

Cormorant Asset Management reported no remaining Celgene Corp position as of Q2 2016 after selling out during the quarter.
Cormorant Asset Management sold 100,000 Celgene Corp shares in Q2 2016, an estimated $10M.
Cormorant Asset Management first reported a position in Celgene Corp in Q4 2013 and held it in 4 quarters.
Cormorant Asset Management's Celgene Corp position peaked at $33.6M in Q4 2014.
1,218 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2016.

Based on Cormorant Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.